- Home
- PBYI vs SMID Comparison
PBYI vs SMID Comparison
Compare PBYI & SMID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBYI
- SMID
- Stock Information
- Founded
- PBYI 2010
- SMID 1960
- Country
- PBYI United States
- SMID United States
- Employees
- PBYI N/A
- SMID N/A
- Industry
- PBYI Biotechnology: Pharmaceutical Preparations
- SMID Building Materials
- Sector
- PBYI Health Care
- SMID Industrials
- Exchange
- PBYI Nasdaq
- SMID Nasdaq
- Market Cap
- PBYI 164.3M
- SMID 157.4M
- IPO Year
- PBYI N/A
- SMID 1995
- Fundamental
- Price
- PBYI $3.54
- SMID $34.93
- Analyst Decision
- PBYI Strong Buy
- SMID
- Analyst Count
- PBYI 1
- SMID 0
- Target Price
- PBYI $7.00
- SMID N/A
- AVG Volume (30 Days)
- PBYI 306.9K
- SMID 22.0K
- Earning Date
- PBYI 07-31-2025
- SMID 08-13-2025
- Dividend Yield
- PBYI N/A
- SMID N/A
- EPS Growth
- PBYI 143.51
- SMID 866.67
- EPS
- PBYI 0.77
- SMID 1.45
- Revenue
- PBYI $232,709,000.00
- SMID $78,508,000.00
- Revenue This Year
- PBYI N/A
- SMID N/A
- Revenue Next Year
- PBYI N/A
- SMID N/A
- P/E Ratio
- PBYI $4.64
- SMID $24.09
- Revenue Growth
- PBYI 2.68
- SMID 31.77
- 52 Week Low
- PBYI $2.23
- SMID $25.03
- 52 Week High
- PBYI $4.13
- SMID $51.96
- Technical
- Relative Strength Index (RSI)
- PBYI 58.61
- SMID 67.05
- Support Level
- PBYI $3.26
- SMID $32.38
- Resistance Level
- PBYI $3.65
- SMID $32.19
- Average True Range (ATR)
- PBYI 0.14
- SMID 1.54
- MACD
- PBYI 0.01
- SMID 0.57
- Stochastic Oscillator
- PBYI 84.78
- SMID 93.93
About PBYI Puma Biotechnology Inc
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis leading to apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.
About SMID Smith-Midland Corporation
Smith-Midland Corp through its subsidiaries invents, develops, manufactures, markets, sells, and installs precast concrete products for primary use in the construction, highway, utilities, and farming industries. The firm's customers are general contractors and federal, state, and local transportation authorities. Its products include Slenderwall, JJhooks, Softsound, Sierra Wall and Easi set. A substantial portion of the company's business is derived from local, state, and federal building projects. The company generates revenues predominantly from the sale, leasing, licensing, shipping, and installation of precast concrete products for the construction, utility, and farming industries.